Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer

This study has been terminated.
Information provided by (Responsible Party):
Sun Pharma Advanced Research Company Limited Identifier:
First received: May 9, 2014
Last updated: October 20, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2016
  Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)